Evotec receives €3 million payment for Bayer starting phase-II clinical development of DNP programme Read more
Copper Histidinate data to be presented at 2022 American College of Medical Genetics Annual Clinical Genetics Meeting Read more
Astellas’ fezolinetant fails to meet pre-defined endpoints for efficacy in Moonlight clinical trial Read more
Bayer submits application in EU for extension of finerenone to include early stages of CKD associated with type-II diabetes Read more